Category: Prescription Drugs
Kaiser Health News editor praises Trump plan to require drug prices in TV ads
Kaiser Health News Editor-in-Chief Dr. Elisabeth Rosenthal expressed optimism over President Donald Trump’s proposal to require drug companies to list prices in TV commercials, part of his overall plan to bring down prescription medicine costs.
Read More
To access this content, you must purchase a Premium membership, or log in if you are a member.
Drugmakers, PBMs and policymakers face off at NAIC on drug pricing
Organizations representing drugmakers and pharmacy benefits managers faced off with policymakers over healthcare costs at the National Association of Insurance Commissioners national meeting last weekend in Milwaukee.
Read More
To access this content, you must purchase a Premium membership, or log in if you are a member.
Democratic lawmakers, Citizen Action of Wisconsin push legislation targeting generic drug prices
Democratic lawmakers and Citizen Action of Wisconsin unveiled legislation Wednesday that would allow the state’s attorney general to compel drug companies and distributors to justify high price hikes for generic drugs and pursue action against them.
Read More
To access this content, you must purchase a Premium membership, or log in if you are a member.
Baldwin backs funding to fight opioid epidemic, stabilize Affordable Care Act
Sen. Tammy Baldwin, D-Wis., recently introduced legislation to provide billions more to states to fight the opioid epidemic. She spoke to Wisconsin Health News this week about the legislation and what’s needed to stabilize the Affordable Care Act’s marketplaces.
Read More
To access this content, you must purchase a Premium membership, or log in if you are a member.
Dane County to pursue lawsuit against opioid manufacturers
The Dane County Board of Supervisors voted last week to give the OK for the county to pursue a lawsuit against opioid manufacturers. More than 80 percent of Wisconsin counties have sued drugmakers alleging that their marketing contributed to the opioid epidemic. The companies involved have denied wrongdoing. “This is a crisis that must be […]
To access this content, you must purchase a Premium membership, or log in if you are a member.
Drug program backers look forward after judge declines to block cuts
Supporters of a program that offers discounted drugs to participating providers are looking to legislation and appealing a decision by a court that declined to block funding cuts that hit the program at the start of the year.
Read More
To access this content, you must purchase a Premium membership, or log in if you are a member.
